Gans is correct - there is precedent in double blind placebo studies ending early.
BUT...being a little Aussie microcap, and not Big Pharma, who knows how the FDA / EMA might react.
Being in the rare disease space is in our favor - with life expectancy of DMD boys in the 20's...waiting an extra 6, 12 or 18 months for the sake of 'regulation' is not acceptable.
Just like many COVID vaccine programs were rushed through by the FDA in the 'interest of public health'.
Time will tell.
.
Lets see how we go!
.
